Purchase Order 75N92E24P00240
Award Date 9/20/24
Potential Completion Date 3/31/25
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $16,875 firm fixed price purchase order to Bionano Genomics, Inc. to deliver NEXUS COPY NUMBER DISCOVERY services for one year. The contract will support the NIH National Human Genome Research Institute's genomic research efforts through Bionano Genomics' single-molecule optical mapping technology, which enables structural variant detection and advanced genome analysis....
- Bionano Genomics, Inc. was awarded a $24,115.32 firm fixed-price purchase order by the National Institutes of Health (NIH) Clinical Center on June 12, 2025, with an ultimate completion date of July 17, 2025. This contract, issued without a small business set-aside designation, represents a direct procurement of genomic research materials or equipment from the San Diego-based manufacturer. The award leverages the company's established expertise in optical genome mapping technology and...
- The NIH Clinical Center awarded a $25,624.35 firm fixed price purchase order to Bionano Genomics, Inc. for the procurement of reagents to support optical genome mapping experiments. The contract, which was awarded on September 19, 2025, with an ultimate completion date of September 18, 2026, includes no small business set-aside designation. Bionano Genomics, a San Diego-based manufacturer specializing in advanced genomic analysis solutions, will provide consumable materials and reagents...
- Bionano Genomics, Inc. has been awarded a firm fixed price purchase order from the Department of Health and Human Services' National Institutes of Health Clinical Center worth $68,747.30 to supply BIONANO PREP SP-G2 BMA 12 GENOME BUNDLE, G3.3 KITS. The kits include consumables to map 12 human genomes and will support the NIH Clinical Center's genomic research efforts. Performance will take place in San Diego, California by March 2024. No subcontractors or set-aside designation were specified....
- The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health, awarded a BPA call contract valued at $11,736.50 to 10X Genomics, Inc., a biotechnology company based in Pleasanton, California. Under this firm fixed-price contract awarded on August 4, 2023, 10X Genomics will provide genomic analysis products and reagents to support federal biomedical research initiatives. The contract carries no set-aside designation and represents a delivery...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services. The contract was awarded to 10X Genomics, Inc., a life sciences technology company that specializes in products and services for single-cell and spatial analysis applications. The purpose of this $15,550.20 contract is to provide 10X Genomics optimization...
- 10X Genomics, Inc. was awarded a Blanket Purchase Agreement (BPA) call valued at $11,448.65 by the National Human Genomics Research Institute (NHGRI) on November 2, 2022, with an ultimate completion date of November 30, 2023. This firm fixed-price contract, which does not include a set-aside designation, was issued under an existing BPA vehicle. The company will perform work at its headquarters location in Pleasanton, California. As a leading biotechnology firm specializing in advanced genomic...
- The National Human Genome Research Institute (NHGRI), an agency within the National Institutes of Health, awarded 10X Genomics, Inc. a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $13,088.35 for single-cell RNA sequencing experiments and Assay for Transposase-Accessible Chromatin with Sequencing (ATAC-seq) services. The contract was awarded on April 13, 2022, with an ultimate completion date of March 31, 2023, with no set-aside designation applied. Work will be performed at...
- This is a firm fixed-price BPA call contract awarded by the National Institute of Mental Health (NIMH), a civilian agency, to 10X Genomics, Inc., a for-profit biotechnology manufacturer, for $24,906.17. The contract is to provide specialized genomic analysis platforms, reagents, instruments, and bioinformatics software to support advanced biomedical research across domains such as infectious diseases, cancer, neurological disorders, and age-related conditions. 10X Genomics has been awarded...
- The National Human Genome Research Institute (NHGRI), a civilian agency under the National Institutes of Health, awarded a firm fixed-price Blanket Purchase Agreement (BPA) call to 10X Genomics, Inc. for a Dual Index Kit TT Set A 96 Reactions on April 26, 2022. This contract, valued at $24,764.60 with an ultimate completion date of September 30, 2022, was awarded without set-aside designation. The contract will be performed at 10X Genomics' facility in Pleasanton, California, where the company...
This federal contract award is for Bionano Genomics, Inc. to provide a license renewal for the Nexus Copy Number software to the National Human Genome Research Institute (NHGRI). The $16,875 firm fixed-price purchase order supports NHGRI's genomics research initiatives, allowing the agency to analyze genotype data using Bionano's advanced genomic analysis technology. Bionano Genomics is a for-profit manufacturer of scientific instruments and consumables for genetic research, with a history of federal contracting primarily with civilian agencies like the NIH, CDC, and USDA. This contract does not have a small business set-aside designation. The award date is September 20, 2024, with an ultimate completion date of March 31, 2025.
Generated 4/2/25, 10:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 4/1/25 | |
| Not listed | Not listed | $16.9k | 8/6/24 |